GE HealthCare, AWS Team Up On Clinical Generative AI Apps

GE HealthCare and Amazon Web Services (AWS) began a partnership to create purpose-built foundation models and generative artificial intelligence (AI) applications aimed at improving medical diagnostics and patient care.

The collaboration will focus on developing multi-modal foundation models to analyze a huge array of unstructured medical data (records, reports, and images) and provide precise, adaptable insights for various healthcare applications. These models can be used to interpret data for many diseases and tasks simultaneously.

GE HealthCare will use the Amazon Bedrock service to build and launch bespoke generative AI apps, which will be leveraged to boost efficiency, care delivery and patient experience. The company also plans to use the Amazon Q Developer to speed software building via real-time code suggestions and secure completion of tasks. Amazon Q Business will be used to explore the intersection of multi-modal clinical and operational data, in order to reduce physicians’ cognitive burden.

By employing Amazon’s generative AI, GE HealthCare is working to cut clinical app development cycles from months to years.

Further, the company wants to modernize its application suite with foundation models developed on Amazon SageMaker, a service to build, train, and deploy machine learning (ML) models. GE HealthCare plans to use these foundation models for web-based medical imaging applications and spread them across its equipment and software to drive efficiency and interoperability.

The company’s generative AI-powered applications will integrate with AWS HealthLake and AWS HealthImaging to securely analyze patient data, as well.

“By combining generative AI with our deep expertise, we’re igniting a new era in healthcare,” said GE HealthCare’s global chief science and technology officer Dr. Taha Kass-Hout. “Our work with AWS is a big step towards helping clinicians make medical care simpler, more efficient, and deeply personalized. It’s about advancing the way we care for people everywhere, one innovative solution at a time.”

The Chicago-based company has been making large investments in AI for years—it topped the U.S. Food and Drug Administration (FDA) list of AI-enabled medical devices for the third year running. This week, GE HealthCare also revealed a joint development agreement with Volta Medical to develop AI-powered electrophysiology tools for catheter ablation to treat atrial fibrillation.

Last week, the company began a $51 million acquisition deal for Intelligent Ultrasound’s clinical AI software business.